FIELD: chemical technology, pharmaceutical industry. SUBSTANCE: invention relates to application of agent used for protection against oxidation by environment air, namely to activated carbon, in industrial manufacturing and first of all processing derivatives of prostane, namely compounds representing prostacycline with incorporated β-cyclodextrin. Such protective agent against oxidation removes ozone from technological air before its contact with derivatives of prostane. Agent can be used in preparing medicinal agents. Invention provides reducing concentration of decomposition substances. EFFECT: improved and valuable properties of agent. 8 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR OBTAINING MEMBRANE-COVERED SPHERICAL GRANULES OF PROSTANE | 1999 |
|
RU2209060C2 |
| MEDICINAL AGENT FOR TREATMENT MENINGITIS CAUSED BY MICROORGANISMS | 1996 |
|
RU2201232C2 |
| METHOD OF PRODUCING CARBOCYCLINE DERIVATIVES OR PHYSIOLOGICALLY ACCEPTABLE SALTS THEREOF | 0 |
|
SU1380608A3 |
| METHOD FOR TREATING THE CASES OF CHRONIC POLYARTHRITIS | 1993 |
|
RU2179023C2 |
| METHOD FOR PRODUCING DERIVATIVES OF CARBACYCLINES OR THEIR ADDITIVE-BASIC SALTS OF TRIS-(OXYMETHYL)-AMINOMETHAN | 0 |
|
SU1316555A3 |
| METHOD OF PRODUCING DERIVATIVES OF CARBACYCLINE | 0 |
|
SU1367856A3 |
| PROCESS FOR PRODUCING DERIVATIVES OF PROSTACYCLINE OR THEIR SALTS | 0 |
|
SU1003754A3 |
| METHOD OF PRODUCING DERIVATIVES OF (5E)-13,14,18,19,19-HEXADEHYDRO-3-OXA-6A-CARBOPROSTAGLANDIN-1 SUB TWO OR SALTS THEREOF | 0 |
|
SU1384196A3 |
| PROSTOGLANDINE DERIVATIVE POSSESSING BLOOD HYPOTENSIVE EFFECT AND BRONCHODILATIOR EFFECT | 0 |
|
SU1310390A1 |
| METHOD OF OBTAINING CARBACYCLINE DERIVATIVES OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS | 0 |
|
SU1145926A3 |
